Medicina
Departamento
University of Belgrade
Belgrado, SerbiaPublicaciones en colaboración con investigadores/as de University of Belgrade (31)
2023
-
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
JAMA dermatology, Vol. 159, Núm. 8, pp. 837-847
-
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
International Journal of Antimicrobial Agents, Vol. 62, Núm. 4
-
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
eClinicalMedicine, Vol. 58
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
2021
-
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Blood, Vol. 138, Núm. 18, pp. 1768-1773
-
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 6, pp. 801-812
-
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105
-
Mixinyeast: A multicenter study on mixed yeast infections
Journal of Fungi, Vol. 7, Núm. 1, pp. 1-14
2020
-
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey
Mycoses, Vol. 63, Núm. 5, pp. 420-429
-
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Blood, Vol. 136, Núm. 10, pp. 1134-1143
-
Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: A preliminary report
Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1671-1678
-
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study
Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1684-1694
2019
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
European Journal of Internal Medicine, Vol. 60, pp. 54-70
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Journal of Infection, Vol. 79, Núm. 4, pp. 300-311
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
2018
-
Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study
ERJ Open Research, Vol. 4, Núm. 4
-
Toxoplasmosis in transplant recipients, Europe, 2010–2014
Emerging Infectious Diseases, Vol. 24, Núm. 8, pp. 1497-1504
2017
-
Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
European Heart Journal, Vol. 38, Núm. 9, pp. 648-660
-
Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y
World Journal of Emergency Surgery
-
Update of EULAR recommendations for the treatment of systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 76, Núm. 8, pp. 1327-1339